Takemitsu T, Wada H,Hatada T, Ohmori Y, Ishikura K, Takeda T, Sugiyama T, Yamada N, Maruyama K, Katayama N,Isaji S, Shimpo H, Kusunoki M, Nobori T. Prospective Evaluation of three different diagnostic criteria for disseminated intravascular coagulation. Thrombosis and Haemostasis. 2010;(17): 3037-42
Inoue Y, Tanaka K, Hiro J, Toiyama Y, Miki C, Kusunoki M. Multicentre phase II study of leucovorin plus pharmacokinetic modulating chemotherapy for metastatic colorectal cancer. Oncol Lett. 2010 Jan;1(1):81-85.
Miki C, Tanaka K, Toiyama Y, Inoue Y, Uchida K, Mohri Y, Kusunoki M. Comparison of the Prognostic Value of Inflammation –Based Pathologic and Biochemical Criteria in Patients Undergoing Potentially Curative Resection for Colorectal Cancer. Ann Surg. 2010 Feb;251(2):389-90.
Mohri Y, Tanaka K, Ohi M, Yokoe T, Miki C, Kusunoki M. Prognostic significance of host- and tumor-related factors in patients with gastric cancer. World J Surg. 2010 Feb;34(2):285-90.
Nagata S, Shimizu T, Kudo T, Tomomasa T, Tajiri H, Yoden A, Kagimoto S, TaharaT, Ushijima K, Uchida K, Kobayashi A. Efficacy and safety of pulse steroidtherapy in Japanese pediatric patients with ulcerative colitis: a survey of the Japanese Society for Pediatric Inflammatory Bowel Disease.Digestion.2010;81(3):188-92.
Yokoe T, Toiyama Y, Okugawa Y, Tanaka K, Ohi M, Inoue Y, Mohri Y, Miki C, Kusunoki M. KAP1 is associated with peritoneal carcinomatosis in gastric cancer. Ann Surg Oncol. 2010 Mar;17(3):821-8.
Yasuda H, Inoue M, Uchida K, Otake K, Koike Y, Fujikawa H, Miki C, Kusunoki M. Wandering spleen causing intestinal obstruction after repair of congenital diaphragmatic hernia. Eur J Pediatr Surg. 2010 Mar;20(2):121-3.
Uchida K, Araki T, Inoue M, Otake K, Yoshiyama S, Koike Y, Matsushita K, Okita Y, Miki C, Kusunoki M. Poor catch-up growth after proctocolectomy in pediatric patients with ulcerative colitis receiving prolonged steroid therapy. Pediatr Surg Int. 2010 Apr;26(4):373-7.
Kobayashi M, Inoue Y, Mohri Y, Miki C, Kusunoki M. Implementing a standard protocol to decrease the incidence of surgical site infections in rectal cancer surgery. Surg Today. 2010 Apr;40(4):326-33.
Toiyama Y, Inoue Y, Saigusa S, Okugawa Y, Yokoe T, Tanaka K, Miki C, Kusunoki M. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery. Clin Oncol (R Coll Radiol). 2010 May;22(4):272-80.
Toiyama Y, Mizoguchi A, Okugawa Y, Koike Y, Morimoto Y, Araki T, Uchida K, Tanaka K, Nakashima H, Hibi M, Kimura K, Inoue Y, Miki C, Kusunoki M. Intravital imaging of DSS-induced cecal mucosal damage in GFP-transgenic mice using two-photon microscopy. J Gastroenterol. 2010 May;45(5):544-53.
Inoue Y, Kusunoki M. Resection of rectal cancer: a historical review. Surg Today. 2010 Jun;40(6):501-6.
Okamoto K, Wada H, Hatada T, Uchiyama T, Kawasugi K, Mayumi T, Gando S, Kushimoto S, Seki Y, Madoiwa S, Asakura H, Koga S, Iba T, Maruyama. Frequency and hemostatic abnormalities in pre-DIC patients. Thromb Res. 2010 Jul;126(1):74-8.
Ikeuchi H, Uchino M, Matsuoka H, Bando T, Matsumoto T, Tomita N,Syoji Y, Kusunoki M, Yamamura T, Utsunomiya J. Surgery for ulcerative colitis in 1,000 patients. Int J Colorectal Dis. 2010;(25): 959-65.
Sugiyama T, Kobayashi T, Nagao K, Hatada T, Wada H, Sagawa N. Group A streptococcal toxic shock syndrome with extremely aggressive course in the third trimester. J Obstet Gynaecol Res. 2010 Aug;36(4):852-5.
Inoue M, Uchida K, Otake K, Koike Y, Miki C, Kusunoki M. Congenital segmental dilatation of the duodenum: report of a case. Pediatr Int. 2010 Aug;52(4):e184-6.
Saigusa S, Tanaka K, Toiyama Y, Yokoe T, Okugawa Y, Kawamoto A, Yasuda H, Morimoto Y, Fujikawa H, Inoue Y, Miki C, Kusunoki M. Immunohistochemical features of CD133 expression: association with resistance to chemoradiotherapy in rectal cancer. Oncol Rep. 2010 Aug;24(2):345-50.
Saigusa S, Toiyama Y, Tanaka K, Yokoe T, Okugawa Y, Kawamoto A, Yasuda H, Inoue Y, Miki C, Kusunoki M. Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy. Ann Surg Oncol. 2010 Aug;17(8):2051-8.
Wada H, Hatada T, Okamoto K, Uchiyama T, Kawasugi K, Mayumi T, Gando S, Kushimoto S, Seki Y, Madoiwa S, Okamura T, Toh CH. Modified non-overt DIC diagnostic criteria predict the early phase of overt-DIC. Am J Hematol. 2010 Sep;85(9):691-4.
Okugawa Y, Miki C, Toiyama Y, Yasuda H, Yokoe T, Saigusa S, Hiro J, Tanaka K, Inoue Y, Kusunoki M. Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer. Br J Cancer. 2010 Sep 7;103(6):787-95.
Hiro J, Inoue Y, Toiyama Y, Yoshiyama S, Tanaka K, Mohri Y, Miki C, Kusunoki M. Possibility of paclitaxel as an alternative radiosensitizer to 5-fluorouracil for colon cancer. Oncol Rep. 2010 Oct;24(4):1029-34.
Inoue Y, Yokobori T, Yokoe T, Toiyama Y, Miki C, Mimori K, Mori M, Kusunoki M. Clinical significance of human kallikrein7 gene expression in colorectal cancer. Ann Surg Oncol. 2010 Nov;17(11):3037-42.
Okugawa Y, Toiyama Y, Inoue Y, Saigusa S, Kobayashi M, Tanaka K, Mohri Y, Miki C, Kusunoki M. Late-onset peritoneal recurrence of advanced gastric cancer 20 years after primary resection. World J Surg Oncol. 2010 Nov 24;8:104.
Toiyama Y, Miki C, Inoue Y, Minobe S, Urano H, Kusunoki M. Loss of tissue expression of interleukin-10 promotes the disease progression of colorectal carcinoma. Surg Today. 2010;40(1):46-53.
Non-Pub-Med
Okugawa Y,Miki C, Toiyama Y,Koike Y, Yokoe T, Saigusa S, Tanaka K,Inoue Y, Kusunoki M. Soluble VCAM-1 and its relation to disease progression in colorectal carcinoma. Exp Ther Med 2010; (1):463-69